MedTrace Logo

Evaluation of the Efficacy of the Sequencing Method by Gene-panel

NCT02954640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2018-03-15

No results posted yet for this study

Summary

In order to accelerate the identification of genes responsibles of PID, and to improve the diagnosis of PID, the research team would like to validate a rapid and targeted method of high-throughput sequencing, on 301 genes, known to be involved in PID.

Conditions

  • Primary Immuno-Deficiencies

Interventions

BIOLOGICAL

Blood sampling

Additional blood sampling for the realization of the test on the gene panel

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • Imagine Institute

    lead OTHER

Principal Investigators

  • Alain Fischer · Imagine Institute

  • Alexandre Alcais · Imagine Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-09-08
Completion
2017-09-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02954640 on ClinicalTrials.gov